Odborná konference

Dr. Ilya Reznik is a Board-certified specialist in Adult Forensic & Clinical Neuropsychiatry at MaReNa Diagnostic and Consulting Center, Israel.
He has an outstanding educational and professional background, with significant contributions to neuropsychiatric research, including numerous publications, clinical trials, and innovative activities. Dr. Reznik has authored numerous original papers, reviews, and case reports in leading peer-reviewed journals in clinical psychiatry and neuropsychopharmacology.

His primary research focus is on the medicinal use of cannabis and cannabinoids for various neuropsychiatric disorders, including chronic pain syndrome, fibromyalgia, post-traumatic stress disorder (PTSD), epilepsy, traumatic brain injury, OCD, ADHD, Gilles de la Tourette syndrome, chronic headache, Parkinson’s disease, and Alzheimer’s disease.

Over the past 17 years, Dr. Reznik has gained extensive clinical and research experience in the application of cannabis-based treatments in neuropsychiatry and integrative medicine. He coordinates the Israel National Forum for Medical Cannabis Research & Treatment and has served as a professional advisor to the Israeli Parliament (Knesset) Committee for Drug and Alcohol Control and the Parliamentary Public Lobby for Medicinal Cannabis.

Dr. Reznik is a renowned international speaker on cannabinoid medicine. He is an Associate Member of both the Canadian Consortium for the Investigation of Cannabinoids (CCIC) and the International Cannabinoid Research Society (ICRS). In 2013, he was elected to the Board of Directors of the International Association for Cannabinoid Medicines (IACM).

In 2019, Dr. Reznik was appointed as the IACM Secretary for Partnership & Networking, where he actively promotes educational initiatives and international collaborations within the IACM community. In 2025 Dr. Reznik was elected as the Active/Interim Chairman of Board of Directors of the International Alliance for Cannabinoid Medicines (IACM).